Menarini Korea is a market leader in the key therapeutic areas of Cardiovascular, Oncology, Urology and Consumer Health. Our team of over 120 employees drive clinical development, regulatory approval, market access, pharmacovigilance, product launches and lifecycle management – operating throughout the commercial value chain in support of the world’s leading bio-pharmaceutical companies.

Armed with global resources and local customer insights, we serve hospitals, healthcare providers and consumers with the best medical innovations and quality solutions to enhance the country’s healthcare. Since establishing our presence in Korea on 1 March 2013, we have amassed a diverse portfolio of proprietary and partnered brands and enjoy steady growth. Leveraging license partnerships as well as research and development efforts, Menarini Korea is committed to increasing its pipeline of innovative medical solutions to bridge healthcare needs throughout the country.